Zoetis Inc

NYSEMKT:ZTS ISIN:US98978V1035

Zoetis (NYSE:ZTS)  is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.

 
    

News

Anatara Lifesciences Ltd (ASX:ANR) Receives Second Payment for Detach Under The Agreement with Zoetis (NYSE:ZTS)

🕔1/30/2017 10:20:19 AM 6352

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that it has received a second payment under the exclusive Evaluation and License Option Agreement with the leading global animal health company Zoetis Inc. (NYSE:ZTS) for Detach(TM), Anatara's non-antibiotic anti-infective product.

Read Full Article
###

2,229 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 29) (Since Published: 2229) 

Company Data

    Telephone
  • 1-888-963-8471 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.zoetis.com
  • E:
  • zoetismedia@zoetis.com

Social Media